Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
about
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potentAnalogues of luteinizing hormone-releasing hormone containing cytotoxic groupsA chemically labeled cytotoxic agent: two-photon fluorophore for optical tracking of cellular pathway in chemotherapySelective coupling of methotrexate to peptide hormone carriers through a gamma-carboxamide linkage of its glutamic acid moiety: benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate activation in salt couplingNeuropeptide growth factors.Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.Peptide-mediated targeted drug delivery.Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer.Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.Tetra-chlorido(4,4'-dimethyl-2,2'-bipyridine-κN,N')platinum(IV).Tetra-chlorido(2,3-di-2-pyridylpyrazine-κN,N)platinum(IV).Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery.Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids
P2860
Q24309593-22677C98-76D5-43DD-A70A-650862E54EFBQ24324532-C879EBDF-52DC-4678-B03B-5186F3CF7364Q30779111-EC03629F-BF3C-4BEF-A109-90D4C6486FCAQ36409272-EA1DD92A-D54D-41F8-8075-6E9785D5FD8EQ36535839-B8A675C7-28C1-4F44-91C0-4F8E822E7FD8Q37271561-470C5A36-509A-4433-9A89-F43E36FA2048Q37387473-18442A4A-E136-4740-B61F-414E5AA919ADQ37785045-55698F8F-99F7-4F87-9282-77363C1ED1F6Q37859389-C1BBB537-79D5-458A-8399-A1B03430A06DQ38882916-3C20E39A-8B14-4AED-B603-F5573158DCAAQ39643108-AEF49661-9B46-4203-B417-CA753467D360Q41811971-DD10C084-6069-465E-ADB8-0AE158AD4BDCQ41840955-47B19B94-8B17-47DB-A15D-91A03FDD71E0Q42828662-8D60367C-E842-4D11-AE4C-6CE2DF06A043Q55082165-C0B8778C-FFC7-4764-9ADE-8128D4ABED21Q57821212-40EB1F30-C5F3-4C1F-9435-C2E6DF3E9E0C
P2860
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
description
1989 nî lūn-bûn
@nan
1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@ast
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@en
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@nl
type
label
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@ast
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@en
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@nl
prefLabel
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@ast
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@en
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@nl
P2093
P2860
P356
P1476
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
@en
P2093
A V Schally
G Srkalovic
T W Redding
V J Csernus
P2860
P304
P356
10.1073/PNAS.86.16.6313
P407
P577
1989-08-01T00:00:00Z